Design-driven, multi-use research agendas to enable applied synthetic biology for global health

Systems and Synthetic Biology

Volumn 7, Issue 3, 2013, Pages 79-86

  Carothers, James M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Computer aided design; Model driven design and engineering

Indexed keywords

EID: 84881558283     PISSN: 18725325     EISSN: 18725333     Source Type: Journal    
DOI: 10.1007/s11693-013-9118-2     Document Type: Article

References (54)

1. American Chemical Society (2012) The discovery and development of penicillin. http://acswebcontent. acs. org/landmarks/landmarks/penicillin/pharma. html. Accessed 25 Jan 2012.
2. Bennett G, Gilman N, Stavrianakis A, Rabinow P (2009) From synthetic biology to biohacking: are we prepared? Nat Biotechnol 27: 1109-1111.
3. Billi D, Wright DJ, Helm RF et al (2000) Engineering desiccation tolerance in Escherichia coli. Appl Environ Microbiol 66: 1680-1684.
4. Blanc V, Gil P, Bamas Jacques N et al (1997) Identification and analysis of genes from Streptomyces pristinaespiralis encoding enzymes involved in the biosynthesis of the 4 dimethylamino l phenylalanine precursor of pristinamycin I. Mol Microbiol 23: 191-202.
5. Blount BA, Weenink T, Ellis T (2012) Construction of synthetic regulatory networks in yeast. FEBS Lett. doi: 10. 1016/j. febslet. 2012. 01. 053.
6. Bokinsky G, Peralta-Yahya PP, George A et al (2011) Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coli. Proc Natl Acad Sci USA 108: 19949-19954.
7. Carothers JM, Goler JA, Keasling JD (2009) Chemical synthesis using synthetic biology. Curr Opin Biotechnol 20: 498-503.
8. Carothers JM, Goler JA, Kapoor Y et al (2010) Selecting RNA aptamers for synthetic biology: investigating magnesium dependence and predicting binding affinity. Nucleic Acids Res 38: 2736-2747.
9. Carothers JM, Goler JA, Juminaga D, Keasling JD (2011) Model-driven engineering of RNA devices to quantitatively program gene expression. Science 334: 1716-1719.
10. Chang MCY, Keasling JD (2006) Production of isoprenoid pharmaceuticals by engineered microbes. Nat Chem Biol 2: 674-681.
11. Chau PC (2002) Process control: a first course with MATLAB. Cambridge University Press, Cambridge.
12. Chen J, Densmore D, Ham TS et al (2012) Device editor visual biological CAD canvas. J Biol Eng 6: 1.
13. Dana GV, Kuiken T, Rejeski D, Snow AA (2012) Synthetic biology: four steps to avoid a synthetic-biology disaster. Nature 483: 29. doi: 10. 1038/483029a.
14. Deana A, Celesnik H, Belasco JG (2008) The bacterial enzyme RppH triggers messenger RNA degradation by 5-prime pyrophosphate removal. Nature 451: 355-358. doi: 10. 1038/nature06475.
15. Dietrich JA, Fortman JL, Juminaga D, Keasling JD (2011) Microbial production of plant-derived pharmaceutical natural products through metabolic engineering: artemisinin and beyond. In: Tao J, Kazlauskas R (eds) Biocatalysis for green chemistry and chemical process development, Wiley, Hoboken, NJ, USA.
16. Duffy JL, Kirk BA, Wang L et al (2007) 4-Aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV. Bioorg Med Chem Lett 17: 2879-2885.
17. Fleishman SJ, Whitehead TA, Ekiert DC et al (2011) Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332: 816.
18. Goikhman MY, Subbotina LI, Martynenkov AA et al (2011) Synthesis and optical properties of copolymers of 4-aminostyrene with the side styrylquinoline chromophore groups. Russ Chem Bull 60: 295-303.
19. Goler JA, Bramlett BW, Peccoud J (2008) Genetic design: rising above the sequence. Trends Biotechnol 26: 538-544.
20. Gostin LO (2007) Meeting basic survival needs of the world's least healthy people: toward a framework convention on global health. Georget Law J 96: 331-392.
21. Gutmann A, Wagner J (2010) New directions: the ethics of synthetic biology and emerging technologies. Presidential Commission for the Study of Bioethical Issues, Washington, DC.
22. Hazen RM, Griffin PL, Carothers JM, Szostak JW (2007) Functional information and the emergence of biocomplexity. Proc Natl Acad Sci 104: 8574-8581.
23. Hersch F (2012) Transforming health care: one SMS at a time? Transl Glob Health. http://blogs. plos. org/globalhealth/2012/12/26/transforming-health-care-one-sms-at-a-time/. Accessed 26 Dec 2012.
24. Hillson NJ, Rosengarten RD, Keasling JD (2011) j5 DNA assembly design automation software. ACS Synth Biol 1: 14-21.
25. Holtz WJ, Keasling JD (2010) Engineering static and dynamic control of synthetic pathways. Cell 140: 19-23. doi: 10. 1016/j. cell. 2009. 12. 029.
26. Huo YX, Cho KM, Rivera JG et al (2011) Conversion of proteins into biofuels by engineering nitrogen flux. Nat Biotechnol 29: 346-351.
27. Johnson IS (1983) Human insulin from recombinant DNA technology. Science 219: 632-637.
28. Juminaga D, Baidoo EE., Redding-Johanson AM et al. (2012) Modular engineering of l-tyrosine production in Escherichia coli. Appl Environ Microbiol 78(1): 89-98. doi: 10. 1128/AEM. 06017-11.
29. Keasling JD (2010) Manufacturing molecules through metabolic engineering. Science 330: 1355.
30. Khatib F, Cooper S, Tyka MD et al (2011) Algorithm discovery by protein folding game players. Proc Natl Acad Sci 108: 18949-18953.
31. Koblentz GD (2009) Living weapons: biological warfare and international security. Cornell University Press, Ithaca, NY.
32. Koeppl H (2011) Design and analysis of bio-molecular circuits. Springer, Berlin.
33. Lee SK, Chou H, Ham TS et al (2008) Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Curr Opin Biotechnol 19: 556-563.
34. Marchetti E, Mazarin-Diop V, Chaumont J et al (2012) Conducting vaccine clinical trials in sub-Saharan Africa: operational challenges and lessons learned from the Meningitis Vaccine Project. Vaccine.
35. Mead C, Conway L (1980) Introduction to VLSI systems. Addison-Wesley Reading, MA.
36. Medema MH, van Raaphorst R, Takano E, Breitling R (2012) Computational tools for the synthetic design of biochemical pathways. Nat Rev Microbiol 10: 191-202. doi: 10. 1038/nrmicro2717.
37. Oye KA, Wellhausen R (2010) Synthetic biology: the technoscience and its societal consequences. Springer, Berlin, pp 121-140.
38. Peralta-Yahya PP, Ouellet M, Chan R et al (2011) Identification and microbial production of a terpene-based advanced biofuel. Nat Commun 2: 483.
39. Reid AB, Daffy JR, Stanley P, Buising KL (2010) Use of pristinamycin for infections by gram-positive bacteria: clinical experience at an Australian Hospital. Antimicrob Agents Chemother 54: 3949-3952.
40. Rezaie R, McGahan AM, Daar AS, Singer PA (2012) Innovative drugs and vaccines in China, India and Brazil. Nat Biotechnol 30: 923-926.
41. Rip A, Kemp RPM (1998) Technological change. In: Rayner S, Malone EL (eds) Human choice and climate change. Resources and Technology, vol II. Battelle Press, Columbus, Ohio, pp 327-399.
42. Ro D-K, Paradise EM, Ouellet M et al (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-943. doi: 10. 1038/nature04640.
43. Roose-Snyder B, Doyle MK (2009) The global health licensing program: a new model for humanitarian licensing at the university level. Am J Law Med 35: 281-700.
44. Rosicrucian Egyptian Museum (2012) Rosicrucian Egyptian Museum Virtual Gallery. Brewery Scene Model (2000 B. C. E.). http://www. egyptianmuseum. org/dailylifegallery. Accessed 16 July 2013.
45. Saltelli A, Ratto M, Andres T et al (2008) Global sensitivity analysis: the primer. Wiley, England.
46. Sariaslani FS (2007) Development of a combined biological and chemical process for production of industrial aromatics from renewable resources. Annu Rev Microbiol 61: 51-69.
47. Shiue E, Prather KLJ (2012) Synthetic biology devices as tools for metabolic engineering. Biochem Eng J. doi: 10. 1016/j. bej. 2012. 04. 006.
48. Steen EJ, Kang Y, Bokinsky G et al (2010) Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature 463: 559-562.
49. Towse A, Kettler H (2005) Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policies. Bull World Health Organ 83: 301-307.
50. Wagner CS, Brahmakulam I, Jackson B et al (2001) Science and technology collaboration: building capability in developing countries (No. RAND/MR-1357. 0-WB). RAND Corp., Santa Monica, CA.
51. Westfall PJ, Pitera DJ, Lenihan JR et al (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci 109: E111-E118. doi: 10. 1073/pnas. 1110740109.
52. Yager P, Domingo GJ, Gerdes J (2008) Point-of-care diagnostics for global health. Annu Rev Biomed Eng 10: 107-144. doi: 10. 1146/annurev. bioeng. 10. 061807. 160524.
53. Zhang F, Keasling J (2011) Biosensors and their applications in microbial metabolic engineering. Trends Microbiol 19: 323-329.
54. Zhang F, Carothers JM, Keasling JD (2012) Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids. Nat Biotechnol 30: 354-359. doi: 10. 1038/nbt. 2149.